Status:
RECRUITING
A Chatbot to Support Substance Use Recovery
Lead Sponsor:
Dimagi Inc.
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles
Conditions:
Opiate-Related Disorders
Opiate Substitution Treatment
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder. Can t...
Eligibility Criteria
Inclusion Criteria:
- 18-65 years old
- Comfortable with reading, understanding, and communicating in English
- Receiving medication treatment for OUD at MGH?
- Able to participate in a remote interview?
- Own or have reliable access to Wi-Fi or a cellular network
- Willing to use a mobile device to access the chatbot?
Exclusion Criteria:
- Has any cognitive, visual, or auditory impairments that may prevent the participant from using the chatbot on a mobile device?
- Unstable medical condition that compromises the ability to safely participate
Key Trial Info
Start Date :
March 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06845878
Start Date
March 7 2025
End Date
September 1 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114